Viewpoints in clinical proteomics: When will proteomics deliver clinically useful information?

Proteomics - Clinical Applications

Volumn 6, Issue 7-8, 2012, Pages 343-345

  Borrebaeck, Carl A K ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Biobanks; Bioinformatics; Over fitting; Pre validation; Signatures

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; AMINO ACID COMPOSITION; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BAYESIAN LEARNING; BIOINFORMATICS; BLOOD SAMPLING; CANCER LOCALIZATION; CANCER STAGING; CANCER TISSUE; EARLY DIAGNOSIS; HUMAN; MASS SPECTROMETRY; METASTASIS; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SUPPORT VECTOR MACHINE; VALIDATION PROCESS;

ALGORITHMS; BIOLOGICAL MARKERS; DATABASES, PROTEIN; HUMANS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84865587204     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200020     Document Type: Article

References (9)

1. Kiyonami, R., Schoen, A., Prakash, A., Peterman, S. et al., Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell Proteomics Feb. 2011, 10, M110.002931.
2. Borrebaeck, C. A. K.,Wingren, C., Design of high-density antibody microarrays for disease proteomics: key technological issues. J. Proteomics 2009, 72, 928-935.
3. Poetz, O., Hoeppe, S., Templin,M. F., Stoll, D. et al., Proteome wide screening using peptide affinity capture. Proteomics 2009, 9, 1518-23.
4. Wingren, C., James, P., Borrebaeck, C. A. K., Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 2009, 9, 1511-1517.
5. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. Ser. B (Methodological) 1995, 57, 289-300.
6. Carlsson, A., Wingren, C., Kristensson, M., Rose, C. et al., Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc. Natl. Acad. Sci. USA 2011, 108, 14252-14257.
7. Polanski, M., Anderson, N. L., A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights 2006, 2, 1-48.
8. Hartmann, M., Roeraade, J., Stoll, D., Templin, M. F. et al., Protein microarrays for diagnostic assays. Anal. Bioanal. Chem 2009, 393, 1407-1416.
9. Haab, B. B., Applications of antibody array platforms. Curr. Opin. Biotechnol. 2006, 4, 415-21.